On August 5, 2021, Genomictree Inc. (KOSDAQ:A228760) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22,350 KRW | -1.97% | -3.46% | +8.50% |
2023 | Genomictree Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2022 | Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.50% | 384M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- A228760 Stock
- News Genomictree Inc.
- Genomictree Inc. announced that it has received KRW 5.00000105 billion in funding from ORION Holdings Corp.